Pre-Filled Auto Injectors Market

As per the recent study by FutureWise on prefilled syringes, the global market is predicted to value over US$ 10 Bn by the end of the assessment year 2026. Prefilled syringes are utilised to package a variety of medications and drugs, such as vaccines, therapeutic proteins and insulin. In recent years, prefilled syringes have gained colossal demand as it is affordable, accurate, convenient and safe. Healthcare specialists benefit from precise, pre-measured dosages, elimination of medication and dosage errors, and reduced risk of microbial contamination.
Despite holding multiple benefits, factors such as high manufacturing cost of prefilled syringes, storage difficulties, and stringent norms set by government authorities may hinder the growth of the market. Nonetheless, manufacturers should focus on technological improvements and innovations, and catering to the unmet demand for specific syringes as these are the key market growth aspects.

Increase in Prevalence of Chronic Diseases Globally to Augment the Growth of Prefilled Syringes Market:

Owing to the rising incidences of chronic diseases globally, healthcare professionals are exploring seeking alternate methods for patient care. As per the Centres for Disease Control and Prevention in 2014, approximately 29.1 million people in the United States were suffering from diabetes, which is 9.3% of the total population. Patients suffering from Type 1 diabetes are advised to undergo periodic intravenous administration of insulin to control their sugar levels inefficiency in natural insulin production. Prefilled syringes assist in self-administration of these drugs by making the treatment affordable, feasible and precise. Due to the rising incidents of chronic diseases in North America, the market displays notable growth.
APEJ region is poised to exhibit growing inclination towards injectable drug delivery systems. The growing ageing population in countries such as India and China, and increasing initiatives in the pharmaceutical industry, is surging the demand for prefilled syringes to treat diabetes and other autoimmune diseases.

Further Significant Highlights:
+ Glass prefilled syringes are forecasted to account for the largest market share. The growth of this segment can be associated with the soaring use of glass in manufacturing syringes due to its resistance towards chemical and heat, and nonreactive nature.
+ Single-chamber prefilled syringes are poised to dominate the market owing to the growing adoption of self-administered parenteral drugs
+ The market for prefilled syringe manufacturing is concentrated; nevertheless, innovative technologies in packaging material contributed by new players can be adapted to manufacture auto-injectors

37B, Koregoan park, Pune ,Maharastra, India
vaibhav@futurewiseresearch.com
Phone +919404822218

FutureWise Research & Consulting was created with the vision of empowering decision-makers with the market intelligence they need most. In an era inundated with numbers, we provide clarity. Filtering through the noise, we present insights and analyses into markets, industries and the competition, allowing companies to focus their resources towards effective strategising.
We deliver actionable insights backed by evidence-based research and in-depth knowledge,customised to the clients’ needs. The addition of key commercial know-how and branding and marketing expertise ensures that we guide organisations to their intended goal – whether that is evaluating revenue opportunities, new launches, brand positioning or maintaining brand equity. With the market intelligence we secure, our clients are equipped with key insights into future disruptions, enabling them to strategise well in advance.

This release was published on openPR.